Literature DB >> 20134186

Interleukin-1 resets glucose homeostasis at central and peripheral levels: relevance for immunoregulation.

Hugo O Besedovsky1, Adriana Del Rey.   

Abstract

We briefly discuss here evidence showing that the capacity of IL-1beta to mediate adjustments of glucose homeostasis can be added to the already well-known pleiotropic effects of this cytokine. Such adjustments, which are necessary for satisfying the high energetic demands of immune/inflammatory responses, can be mediated by effects of endogenous IL-1 exerted at peripheral and brain levels in a concerted action with other cytokines and neuroendocrine mechanisms. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20134186     DOI: 10.1159/000258707

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  2 in total

1.  Interleukin-1β Inhibition for Chronic Kidney Disease in Obese Mice With Type 2 Diabetes.

Authors:  Yutian Lei; Satish K Devarapu; Manga Motrapu; Clemens D Cohen; Maja T Lindenmeyer; Solange Moll; Santhosh V Kumar; Hans-Joachim Anders
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

2.  Acute Inflammation Alters Brain Energy Metabolism in Mice and Humans: Role in Suppressed Spontaneous Activity, Impaired Cognition, and Delirium.

Authors:  John Kealy; Carol Murray; Eadaoin W Griffin; Ana Belen Lopez-Rodriguez; Dáire Healy; Lucas Silva Tortorelli; John P Lowry; Leiv Otto Watne; Colm Cunningham
Journal:  J Neurosci       Date:  2020-06-08       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.